New cancer drug BNT314 enters first human safety trial
NCT ID NCT06150183
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is the first time BNT314 is being tested in humans. It aims to see if the drug is safe for people with advanced solid tumors that have not responded to other treatments. About 41 participants will receive different doses to find the highest dose that is still safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Liège
Liège, 4000, Belgium
-
Carolina BioOncology Institute, LLC
Huntersville, North Carolina, 28078, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
GZA Ziekenhuizen
Antwerp, 2018, Belgium
-
Hospital Fund. Jiménez Dia
Madrid, 28040, Spain
-
Hospital HM Univ. Sanchinarro, Ensayos START
Madrid, 28050, Spain
-
Hospital Quironsalud Barcelona (NEXT Barcelona)
Barcelona, 08023, Spain
-
National Cancer Center Hospital East
Kashiwanoha, 277-8577, Japan
-
Northern Centre for Cancer Care
Newcastle, NE7 7DN, United Kingdom
-
Rigshospitalet
Copenhagen, DK-2100, Denmark
-
Royal Marsden Hospital - London
London, SW36JJ, United Kingdom
-
START Midwest
Grand Rapids, Michigan, 49546, United States
-
The Christie Hospital
Manchester, M20 4BX, United Kingdom